Andrew Darlington
About
Andrew Darlington is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Surgery.
According to data from OpenAlex, Andrew Darlington has authored 24 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 7 papers in Pharmacology and 5 papers in Surgery. Recurrent topics in Andrew Darlington's work include Antiplatelet Therapy and Cardiovascular Diseases (20 papers), Diabetes Treatment and Management (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Andrew Darlington is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (20 papers), Diabetes Treatment and Management (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Andrew Darlington collaborates with scholars based in United States, United Kingdom and Japan. Andrew Darlington's co-authors include Dominick J. Angiolillo, Bhaloo Desai, José Luis Ferreiro, Theodore A. Bass, Masafumi Ueno, Antonio Tello‐Montoliu, Davide Capodanno, Kodlipet Dharmashankar, Fabiana Rollini and Luis A. Guzmán and has published in prestigious journals such as Journal of the American College of Cardiology, Thrombosis and Haemostasis and Circulation Heart Failure.
In The Last Decade
Andrew Darlington
22 papers receiving 683 citations
Peers
Andrew Darlington
Chantal Pharand Canada
Paul A. Gurbel United States
Jin‐Sin Koh South Korea
Bhaloo Desai United States
Seok‐Jae Hwang South Korea
Anders Hägg Sweden
Magdi Ghali United States
Michel Joyal Canada
W. Dieter Paar Germany
Keith Finnie Canada
Citations per year, relative to Andrew Darlington Andrew Darlington (= 1×)
peers
Chantal Pharand
Countries citing papers authored by Andrew Darlington
Since
Specialization
Citations
This map shows the geographic impact of Andrew Darlington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Darlington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Darlington more than expected).
Fields of papers citing papers by Andrew Darlington
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Andrew Darlington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Darlington. The network helps show where Andrew Darlington may publish in the future.
Co-authorship network of co-authors of Andrew Darlington
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Darlington. A scholar is included among the top collaborators of Andrew Darlington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Darlington. Andrew Darlington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Darlington, Andrew. (2025). Hopf–Galois structures on parallel extensions. Journal of Algebra. 679. 1–27.
2.
Darlington, Andrew. (2024). Hopf-Galois structures on separable field extensions of degree pq. Journal of Pure and Applied Algebra. 228(7). 107653–107653.
3.
Rollini, Fabiana, Francesco Franchi, Antonio Tello‐Montoliu, et al.. (2014). Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor–Mediated Signaling in Prasugrel-Treated Patients. JACC: Cardiovascular Interventions. 7(4). 426–434.
4.
Franchi, Francesco, S. Hammad Jafri, Fabiana Rollini, et al.. (2014). Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists. Journal of Thrombosis and Thrombolysis. 40(1). 118–125.
5.
Rollini, Fabiana, Francesco Franchi, Jung Rae Cho, et al.. (2014). Cigarette Smoking and Antiplatelet Effects of Aspirin Monotherapy Versus Clopidogrel Monotherapy in Patients with Atherosclerotic Disease: Results of a Prospective Pharmacodynamic Study. Journal of Cardiovascular Translational Research. 7(1). 53–63.
6.
Angiolillo, Dominick J., Joseph A. Jakubowski, José Luis Ferreiro, et al.. (2014). Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease. Journal of the American College of Cardiology. 64(10). 1005–1014.
7.
Rollini, Fabiana, Antonio Tello‐Montoliu, Andrew Darlington, et al.. (2013). Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation. Journal of Thrombosis and Thrombolysis. 37(2). 131–138.
8.
Darlington, Andrew, Antonio Tello‐Montoliu, Fabiana Rollini, et al.. (2013). Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease. Thrombosis and Haemostasis. 112(2). 258–265.
9.
Tello‐Montoliu, Antonio, Fabiana Rollini, Francesco Franchi, et al.. (2013). Impact of aspirin dose on adenosine diphosphate-mediated platelet activities. Thrombosis and Haemostasis. 110(10). 777–784.
10.
Ferreiro, José Luis, Masafumi Ueno, Antonio Tello‐Montoliu, et al.. (2012). Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation. Journal of Thrombosis and Thrombolysis. 35(2). 155–164.
11.
Tello‐Montoliu, Antonio, José Luis Ferreiro, Murali Kodali, et al.. (2012). Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus. Journal of Thrombosis and Thrombolysis. 36(1). 14–17.
12.
Capranzano, Piera, José Luis Ferreiro, Masafumi Ueno, et al.. (2012). Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on‐treatment platelet reactivity and diabetes mellitus status. Catheterization and Cardiovascular Interventions. 81(1). 42–49.
13.
Ueno, Masafumi, José Luis Ferreiro, Kodlipet Dharmashankar, et al.. (2011). SERUM COTININE LEVELS ARE ASSOCIATED WITH INCREASED CLOPIDOGREL-INDUCED ANTIPLATELET EFFECTS IN PATIENTS WITH DIABETES MELLITUS AND CORONARY ARTERY DISEASE. Journal of the American College of Cardiology. 57(14). E1919–E1919.
14.
Ferreiro, José Luis, Masafumi Ueno, Salvatore D. Tomasello, et al.. (2011). IMPACT OF CONCOMITANT AND STAGGERED PANTOPRAZOLE INTAKE ON PHARMACODYNAMIC EFFECTS INDUCED BY CLOPIDOGREL. Journal of the American College of Cardiology. 57(14). E1907–E1907.
15.
Capodanno, Davide, Kodlipet Dharmashankar, José Luis Ferreiro, et al.. (2011). PHARMACODYNAMIC EFFECTS OF DIFFERENT ASPIRIN DOSING REGIMENS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CORONARY ARTERY DISEASE. Journal of the American College of Cardiology. 57(14). E1910–E1910.
16.
Angiolillo, Dominick J., Piera Capranzano, José Luis Ferreiro, et al.. (2011). Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy. Thrombosis and Haemostasis. 106(8). 253–262.
17.
Darlington, Andrew, José Luis Ferreiro, Masafumi Ueno, et al.. (2011). Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease. Thrombosis and Haemostasis. 106(7). 67–74.
18.
Ueno, Masafumi, José Luis Ferreiro, Kodlipet Dharmashankar, et al.. (2010). CORRELATION BETWEEN THE VERIFYNOW P2Y12 ASSAY AND LIGHT TRANSMITTANCE AGGREGOMETRY TO MEASURE PLATELET P2Y12 RECEPTOR INHIBITION IN PATIENTS ON CLOPIDOGREL THERAPY. Journal of the American College of Cardiology. 55(10). A206.E1946–A206.E1946.
19.
Ferreiro, José Luis, Masafumi Ueno, Davide Capodanno, et al.. (2010). Pharmacodynamic Effects of Concomitant Versus Staggered Clopidogrel and Omeprazole Intake. Circulation Cardiovascular Interventions. 3(5). 436–441.
20.
Ferreiro, José Luis, Masayuki Ueno, Davide Capodanno, et al.. (2010). Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover study.. PubMed. 3(5). 436–41.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Chantal Pharand Breakdown of academic impact, for papers by Paul A. Gurbel Breakdown of academic impact, for papers by Jin‐Sin Koh Breakdown of academic impact, for papers by Bhaloo Desai Breakdown of academic impact, for papers by Seok‐Jae Hwang Breakdown of academic impact, for papers by Anders Hägg Breakdown of academic impact, for papers by Magdi Ghali Breakdown of academic impact, for papers by Michel Joyal Breakdown of academic impact, for papers by W. Dieter Paar Breakdown of academic impact, for papers by Keith Finnie